The Food and Drug Administration (FDA) has halted a program that allowed the transfer of U.S. citizens’ biological samples to China and other “hostile countries.”
The FDA’s ban and review are a necessary move to bolster U.S. biosecurity against the potential threat of biological warfare and bioterror by the Chinese Communist Party (CCP), said experts who spoke with the Chinese-language edition of The Epoch Times.
In recent decades, China has developed a broad array of specialized medical research capabilities, including genetic engineering. Because of their low handling costs, Chinese facilities have become popular destinations for biological samples.
“This [genetic] data is the key to understanding how different population groups respond biologically,” Sean Lin, former U.S. Army microbiologist, said….
Why US Banned Transfer of Genetic Samples to China
